rs439401
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000623895.1(ENSG00000280087):n.1820T>C variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.67 in 152,334 control chromosomes in the GnomAD database, including 35,521 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (no stars).
Frequency
Genomes: 𝑓 0.67 ( 35477 hom., cov: 33)
Exomes 𝑓: 0.72 ( 44 hom. )
Consequence
ENSG00000280087
ENST00000623895.1 non_coding_transcript_exon
ENST00000623895.1 non_coding_transcript_exon
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.0130
Genes affected
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.66).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.845 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENSG00000280087 | ENST00000623895.1 | n.1820T>C | non_coding_transcript_exon_variant | Exon 1 of 1 | 6 |
Frequencies
GnomAD3 genomes AF: 0.670 AC: 101854AN: 152046Hom.: 35420 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
101854
AN:
152046
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.718 AC: 122AN: 170Hom.: 44 Cov.: 0 AF XY: 0.714 AC XY: 90AN XY: 126 show subpopulations
GnomAD4 exome
AF:
AC:
122
AN:
170
Hom.:
Cov.:
0
AF XY:
AC XY:
90
AN XY:
126
Gnomad4 AFR exome
AF:
AC:
4
AN:
4
Gnomad4 AMR exome
AF:
AC:
2
AN:
2
Gnomad4 ASJ exome
AF:
AC:
3
AN:
4
Gnomad4 EAS exome
AF:
AC:
5
AN:
10
Gnomad4 SAS exome
AC:
0
AN:
0
Gnomad4 FIN exome
AF:
AC:
2
AN:
2
Gnomad4 NFE exome
AF:
AC:
104
AN:
144
Gnomad4 Remaining exome
AF:
AC:
2
AN:
4
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.670 AC: 101979AN: 152164Hom.: 35477 Cov.: 33 AF XY: 0.667 AC XY: 49620AN XY: 74390 show subpopulations
GnomAD4 genome
AF:
AC:
101979
AN:
152164
Hom.:
Cov.:
33
AF XY:
AC XY:
49620
AN XY:
74390
Gnomad4 AFR
AF:
AC:
0.8527
AN:
0.8527
Gnomad4 AMR
AF:
AC:
0.501506
AN:
0.501506
Gnomad4 ASJ
AF:
AC:
0.573529
AN:
0.573529
Gnomad4 EAS
AF:
AC:
0.421572
AN:
0.421572
Gnomad4 SAS
AF:
AC:
0.442371
AN:
0.442371
Gnomad4 FIN
AF:
AC:
0.726981
AN:
0.726981
Gnomad4 NFE
AF:
AC:
0.629425
AN:
0.629425
Gnomad4 OTH
AF:
AC:
0.643466
AN:
0.643466
Heterozygous variant carriers
0
1665
3330
4994
6659
8324
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
788
1576
2364
3152
3940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1880
AN:
3478
ClinVar
Significance: drug response
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
Warfarin response Other:1
Aug 31, 2010
Pharmacogenomics Lab, Chungbuk National University
Significance:drug response
Review Status:no assertion criteria provided
Collection Method:research
- likely responsive
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at